ROHTO
LIVE

Serial Number

79410960

Owner

Rohto Pharmaceutical Co., Ltd.

Attorney

Kathleen S. Ryan

Filing Date

Jun 10, 2024

Add to watchlist:

No watchlists yet
View on USPTO

ROHTO Trademark

Serial Number: 79410960 • Registration: 8131616

ROHTO is a trademark filed by Rohto Pharmaceutical Co., Ltd. on June 10, 2024. The trademark is classified under Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Rohto Pharmaceutical Co., Ltd.

8-1, Tatsuminishi 1-chome, Ikuno-ku Osaka-shi
Osaka 544-8666 , JP

Entity Type: 29

Trademark Details

Filing Date

June 10, 2024

Registration Date

February 10, 2026

Published for Opposition

December 23, 2025

Goods & Services

Pharmaceutical preparations being ophthalmological preparations; pharmaceutical preparations for treatment of cataracts; pharmaceutical preparations for treatment of glaucoma; pharmaceutical preparations for treatment of ocular hypertension; ophthalmic ointments for treatment of eye disease; pharmaceutical preparations for use in eye injections; pharmaceutical preparations for treatment of pinguecula ; pharmaceutical preparations for treatment of chalazion; pharmaceutical preparations for treatment of uveitis; eye drops for treatment of keratoconjunctival epithelial disorder; antibacterial eye drops; antiallergic eye drops; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Analgesics; antipyretic preparations; antibiotics; athletes' foot preparations; medicinal drinks; medicinal hair growth preparations; motion sickness treatment preparations; pharmaceutical preparations for treating diabetes; preparations for treating colds; pharmaceutical preparations, namely, astringents, anti-inflammatory liquid for external use, hypnotic sedatives, antipyretic analgesics, anti-cough drops, and vitamin preparations; reagent paper for medical purposes; oiled paper for medical purposes; adhesive tapes for medical purposes; drug delivery agents in the form of edible wafers for wrapping powdered pharmaceuticals; gauze for dressings; empty capsules for pharmaceuticals; eyepatches for medical purposes; ear bandages; menstruation bandages; menstruation tampons; sanitary napkins; sanitary panties; absorbent cotton for medical purposes; adhesive plasters for medical purposes; bandages for dressings; liquid bandages for skin wounds; breast-nursing pads; cotton swabs for medical use; dental impression materials; baby diapers; adult diapers; baby diaper covers; adult diaper covers; fly catching paper; mothproofing paper; lacteal flour for babies; dietary supplements for human beings; dietetic beverages adapted for medical purposes; dietetic foods adapted for medical purposes; beverages for babies; food for babies; dietary supplements for animals; semen for artificial insemination; stem cells for medical, pharmaceutical or veterinary use; stem cells for regenerative medicine, medicine or veterinary use; stem cells only for medical and veterinary use; diagnostic reagents for medical clinic or medical laboratory use; diagnostic media for bacteriological cultures for medical purposes or veterinary purposes; microorganism culture media for cultivating human cells, human tissues, animal cells, animal tissues, plant cells, plant tissues and microorganism cells, for medical use; cell culture media for medical or veterinary use; pharmaceutical serums made from blood for medical or veterinary use for promoting tissue regeneration and stimulating cell proliferation; pharmaceutical serums made from blood for medical or veterinary use for inducing cell repair; pharmaceutical serums made from blood for medical or veterinary use in regenerative medicine; pharmaceutical serums made from blood for medical or veterinary use in regenerative medicine for promoting tissue regeneration, stimulating cell proliferation, and inducing cell repair; serums made from blood for diagnostic purposes; immunological serums made from blood for medical treatment of cartilage defects, skin wounds, and internal organ diseases; serum made from blood for cell culture; pharmaceutical preparations comprising blood-derived antibodies for use in serotherapy; fumigants only for agricultural purposes; fungicides only for agricultural purposes; rodenticides only for agricultural purposes; insecticides only for agricultural purposes; herbicides being weedkillers; insect-repellents only for agricultural purposes; antiseptics only for agricultural purposes

Antistatic preparations for household purposes; de-greasing preparations for household purposes; rust removing preparations; stain removing benzine; fabric softeners for laundry use; laundry bleach; adhesives for affixing false hair; laundry starch; seaweed gelatine for laundry use (funori); adhesives for affixing false eyelashes; breath freshening preparations for personal hygiene; deodorants for animals; paint stripping preparations; shoe cream; shoe black being shoe polish; nonmedicated soaps and detergents for household use; dentifrices; cosmetics; perfumes and flavourings for beverages being essential oils; perfumes and food flavourings being essential oils; incense; false nails; false eyelashes

Filing History

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
May 14, 2026 OPNX
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 10, 2026 FICR
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 27, 2026 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Apr 27, 2026 OPNR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Feb 10, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Feb 10, 2026 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 23, 2025 NPUB
PUBLISHED FOR OPPOSITION
Dec 23, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 17, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 26, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Nov 25, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 25, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 25, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 25, 2025 CNEA
EXAMINER'S AMENDMENT ENTERED
Oct 27, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Oct 27, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Oct 27, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Oct 27, 2025 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 8, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 8, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 8, 2025 TROA
REFUSAL PROCESSED BY IB
Mar 29, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 12, 2025 RFCS
REFUSAL PROCESSED BY MPU
Mar 12, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 30, 2025 RFCR
NON-FINAL ACTION WRITTEN
Jan 29, 2025 CNRT
ASSIGNED TO EXAMINER
Dec 17, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Dec 11, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 11, 2024 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Dec 11, 2024 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 28, 2024 REPR